Samlyn Capital, LLC Neurocrine Biosciences Inc Transaction History

Samlyn Capital, LLC

  • $6.07 Billion
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $16.7 Million - $20.8 Million
-192,325 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $18.5 Million - $26 Million
192,325 New
192,325 $18.5 Million
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $32.5 Million - $39.4 Million
-387,897 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $28 Million - $35.4 Million
387,897 New
387,897 $32.8 Million

Others Institutions Holding NBIX

# of Institutions
650
Shares Held
97.2M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Samlyn Capital, LLC Portfolio

Follow Samlyn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email